Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8309726 | Clinica Chimica Acta | 2018 | 9 Pages |
Abstract
α1,3fucosylated AGP is a potential biomarker of cancer initiation, progression and response to treatment in cancer patients.
Keywords
AALPBSNeuAcAGPPD-1PODConcanavalin AGlcNAcFucFucoseBSAα1-Acid glycoproteinbovine serum albuminAleuria aurantia lectinN-acetylneuraminic acidenzyme immunoassayEIACon Aphosphate bufferBiomarkerTumorigenesiscomputed tomographyPhosphate buffered salineSodium metaperiodateProgrammed death-1Treatment outcomesN-acetylglucosamineGalGalactoseFucosylated glycans
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Shin Yazawa, Takehiko Yokobori, Kyoichi Kaira, Hiroyuki Kuwano, Takayuki Asao,